Sector
PharmaceuticalsOpen
₹1,372Prev. Close
₹1,364.35Turnover(Lac.)
₹596.39Day's High
₹1,377Day's Low
₹1,32852 Week's High
₹052 Week's Low
₹0Book Value
₹0Face Value
₹10Mkt Cap (₹ Cr.)
3,030.51P/E
27.72EPS
48.14Divi. Yield
10.86No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Equity Capital | 22.72 | 22.72 | 22.72 | 22.72 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 246.57 | 544.08 | 459.21 | 362.05 |
Net Worth | 269.29 | 566.8 | 481.93 | 384.77 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Revenue | 679.32 | 678.34 | 588.52 | 641.25 |
yoy growth (%) | 0.14 | 15.26 | -8.22 | |
Raw materials | -324.98 | -272.51 | -211.34 | -213.11 |
As % of sales | 47.83 | 40.17 | 35.91 | 33.23 |
Employee costs | -35.85 | -40.5 | -38.19 | -55.23 |
| Y/e 31 Mar( In .Cr) | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Profit before tax | 133.88 | 193.27 | 204.91 | 235.67 |
Depreciation | -2.73 | -2.65 | -5.88 | -8.98 |
Tax paid | -45.96 | -63.21 | -60.22 | -70.38 |
Working capital | -301.94 | 66.04 | 102.83 | |
Other operating items |
| Y/e 31 Mar | Mar-2014 | Mar-2013 | Mar-2012 | Mar-2011 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 0.14 | 15.26 | -8.22 | |
Op profit growth | -36.36 | -9.06 | -21.55 | |
EBIT growth | -30.89 | -5.63 | -13.3 | |
Net profit growth | -32.39 | -10.11 | -12.46 |
| Particulars (Rupees in Crores.) | Mar-2006 | Mar-2005 | Mar-2004 | Mar-2003 | Mar-2002 |
|---|---|---|---|---|---|
Gross Sales | 315.39 | 286.22 | 351.41 | 332.98 | 304.73 |
Excise Duty | 28.12 | 30.71 | 37.9 | 35.7 | 30.23 |
Net Sales | 287.27 | 255.5 | 313.51 | 297.27 | 274.5 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 20.3 | 43.02 | 9.01 | 9.07 | 13.71 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,672 | 93.86 | 4,01,288.77 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,835 | 82.12 | 1,81,397.34 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,485 | 24.92 | 1,19,948.65 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,314.2 | 59.26 | 1,12,127.01 | 474 | 0.18 | 2,385 | 224.34 |
Mankind Pharma Ltd MANKIND | 2,578.3 | 56.47 | 1,06,401.47 | 382.46 | 0 | 2,126.59 | 354.71 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Director
K K Maheshwari
Director
S S Lalbhai
Director
Vivek Dhariwal
Company Secretary & Legal Dir.
Neema Thakore
Director
Sekhar Natarajan
Director
S Sridhar
Managing Director
Aijaz Tobaccowalla
Level 6 Platina PNC 59 G Block,
Bandra-Kurla Complex Bandra(E),
Maharashtra - 400098
Tel: 91-22-26574000
Website: http://www.wyethindia.com
Email: neema.thakore@pfizer.com
Plot No 17-24,
Vittal Rao Nagar, Madhapur,
Hyderabad-500081
Tel: 91-040-44655185
Website: -
Email: -
Summary
Wyeth Ltd, a subsidiary of Wyeth, USA is a global leader in pharmaceuticals, consumer healthcare and animal health products. The company is a market leader in oral contraceptives, hormone Therapy, fol...
Read More
Reports by Wyeth Ltd Merged
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.